• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2024 Scientific Session Call For Abstracts
      • 2024 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

Alleviation of Morbid Obesity and its Associated Comorbidities via Laparoscopic Sleeve Gastrectomy

Udai S Sibia, MD, Raquel Redondo, MD, Adam S Weltz, MD, Olmos Holmatova, MD, Paxton Paganelli, Hamid R Zahiri, DO, Timothy R Turner, PhD, Alejandro Gandsas, MD. Anne Arundel Medical Center

Background: Laparoscopic Sleeve Gastrectomy (LSG) is a safe and effective operative treatment for morbid obesity. The purpose of this study was to analyze trends in biochemical parameters and pharmacologic dependence in morbidly obese patients to quantify the impact of LSG on obesity related comorbidities.

Methods: A retrospective review was conducted analyzing a consecutive series LSGs performed between January and April of 2015 at Anne Arundel Medical Center. Analyzed outcomes included patient demographics, intra-operative data, and 30-day wound and non-wound related complications. In addition, post-operative biochemical trends and pharmacologic dependence related to obesity-associated comorbidities were assessed after one year.

Results: One-hundred seventeen patients (85% female) with mean age, BMI, and ASA of 46.5 years, 45.9 kg/m2 and 2.9 were included. Common comorbidities included hypertension (HTN, 81.2%), hyperlipidemia (HLD, 45.3%), gastroesophageal reflux disease (GERD, 41.9%) and diabetes mellitus (DM, 35.0%). Operative data included mean time (66.3 min), blood loss (18 ml) and length of stay (2.0 days). Thirty day wound and non-wound related complications were 0.9% and 2.6%. At one year follow-up, pharmacologic independence or reduction was seen in 93.3% of diabetics, 72.4% of hypertensives, 64.3% of refluxers and 71.4% of hyperlipidemics. Additional decreases were BMI by 76.0% (p<0.0001), hemoglobin A1c by 0.8 mg/dL (p<0.001), blood glucose by 24.9mmHg (p<0.001), systolic blood pressure by 8.7 mmHg (p<0.0001), diastolic blood pressure by 8.6 mmHg (p<.0001) and triglycerides by 42.0 mg/dL (p<0.01). Increases included mean HDL levels by 10.3 mg/dL (p<.001). Overall, mean excess weight loss (EWL) was 52.2% after one year.

Conclusion: The potential of LSG to treat morbid obesity and alleviate its most commonly associated ailments is significant as shown by major weight loss, improved biochemical parameters and independence from pharmacologic therapy. Consideration of LSG in less obese patients with DM, HTN, HLD and/or GERD refractory to medical management may serve as a valuable therapeutic strategy.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 80323

Program Number: P484

Presentation Session: Poster (Non CME)

Presentation Type: Poster

81

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

« Return to SAGES 2017 abstract archive

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064
1-310-437-0544
sagesweb@sages.org
Monday - Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons